S 3098 United States Senate · 118th Congress

Securing Advances and a Variety of Evidence-Based IMD Options Act

S 3098 makes permanent a Medicaid program (Section 1915(l)) allowing states to provide medical assistance for individuals in Institutions for Mental Diseases (IMDs). It requires states to facilitate access to medication-assisted treatment for substance use disorders regardless of treatment setting, and to establish evidence-based placement criteria and care standards for such individuals. States must also conduct a one-time assessment within 12 months of approval to evaluate treatment availability across care levels and medication-assisted treatment services. The bill directly affects Medicaid-enrolled individuals in IMDs with substance use disorders and the states administering their care.
Bill status in committee 1 of 4 stages cleared
Introduction
Oct 2023
Committee Review
Floor Vote
President
Introduced Oct 19, 2023 Last action Oct 19, 2023
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
0
Committee
1
Oct 19, 2023
Committee
Read twice and referred to the Committee on Finance. (text: CR S5112)
upper
Oct 19, 2023
Introduced
Introduced in Senate
upper
1 primary · 3 co-sponsors

Sponsors